Resveratrol enhances the radiosensitivity of nasopharyngeal carcinoma cells by downregulating E2F1

Tan,Yuhui; Wei,Xianli; Zhang,Wenyin; Wang,Xiaolan; Wang,Kun; Du,Biaoyan; Xiao,Jianyong

doi:10.3892/or.2017.5413

Resveratrol enhances the radiosensitivity of nasopharyngeal carcinoma cells by downregulating E2F1

Authors:
- Yuhui Tan
- Xianli Wei
- Wenyin Zhang
- Xiaolan Wang
- Kun Wang
- Biaoyan Du
- Jianyong Xiao
View Affiliations

Affiliations: Department of Biochemistry, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong 510006, P.R. China, Department of Medical Instruments, Guangdong Food and Drug Vocational College, Guangzhou, Guangdong 510520, P.R. China, Department of Pathology, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong 510006, P.R. China
Published online on: January 30, 2017 https://doi.org/10.3892/or.2017.5413
Pages: 1833-1841

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Identification of safe, effective radiosensitizing agents is urgently needed to improve the outcome of radiotherapy in nasopharyngeal cancer (NPC). In this study, we assessed the ability of the polyphenol resveratrol to act as a radiosensitizer in vitro and in vivo. CNE-1 cells were treated with 50 µM resveratrol for 24 h, then irradiated. E2F transcription factor 1 (E2F1) was stably knocked down and overexpressed using lentiviruses. A xenograft model of NPC was established in nude mice using CNE-1 cells. Compared to control DMSO‑treated CNE-1 cells, resveratrol inhibited colony-forming ability and induced G1 phase cell cycle arrest. Radiation survival curves confirmed resveratrol significantly sensitized CNE-1 cells, and resveratrol in combination with 2 Gy irradiation synergistically increased apoptosis. Immunoblotting showed resveratrol dose- and time-dependently downregulated E2F1 and phospho-AKT (p-AKT). Knockdown of E2F1 significantly increased radiosensitivity and downregulated p-AKT; overexpression of E2F1 reversed resveratrol-induced radiosensitivity and upregulated p-AKT. In vivo, 50 mg/kg/day resveratrol and 4 Gy irradiation led to significantly lower tumor volume and tumor weight compared to resveratrol or irradiation alone. Our findings show that resveratrol increases the radiosensitivity of NPC cells by downregulating E2F1 and inhibiting p-AKT, and therefore has potential as a radiosensitizer for NPC.

View Figures

View References

1	Jia WH, Huang QH, Liao J, Ye W, Shugart YY, Liu Q, Chen LZ, Li YH, Lin X, Wen FL, et al: Trends in incidence and mortality of nasopharyngeal carcinoma over a 20–25 year period (1978/1983-2002) in Sihui and Cangwu counties in southern China. BMC Cancer. 6:1782006. View Article : Google Scholar : PubMed/NCBI
2	Su SF, Han F, Zhao C, Chen CY, Xiao WW, Li JX and Lu TX: Long-term outcomes of early-stage nasopharyngeal carcinoma patients treated with intensity-modulated radiotherapy alone. Int J Radiat Oncol Biol Phys. 82:327–333. 2012. View Article : Google Scholar : PubMed/NCBI
3	Xiao WW, Han F, Lu TX, Chen CY, Huang Y and Zhao C: Treatment outcomes after radiotherapy alone for patients with early-stage nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys. 74:1070–1076. 2009. View Article : Google Scholar : PubMed/NCBI
4	Zhou J, Wang L, Xu X, Tu Y, Qin S and Yin Y: Antitumor activity of Endostar combined with radiation against human nasopharyngeal carcinoma in mouse xenograft models. Oncol Lett. 4:976–980. 2012.PubMed/NCBI
5	Lee AW, Ng WT, Hung WM, Choi CW, Tung R, Ling YH, Cheng PT, Yau TK, Chang AT, Leung SK, et al: Major late toxicities after conformal radiotherapy for nasopharyngeal carcinoma-patient- and treatment-related risk factors. Int J Radiat Oncol Biol Phys. 73:1121–1128. 2009. View Article : Google Scholar : PubMed/NCBI
6	Akervall J, Nandalur S, Zhang J, Qian CN, Goldstein N, Gyllerup P, Gardinger Y, Alm J, Lorenc K, Nilsson K, et al: A novel panel of biomarkers predicts radioresistance in patients with squamous cell carcinoma of the head and neck. Eur J Cancer. 50:570–581. 2014. View Article : Google Scholar : PubMed/NCBI
7	Arichi H, Kimura Y, Okuda H, Baba K, Kozawa M and Arichi S: Effects of stilbene components of the roots of Polygonum cuspidatum Sieb. et Zucc. on lipid metabolism. Chem Pharm Bull (Tokyo). 30:1766–1770. 1982. View Article : Google Scholar : PubMed/NCBI
8	Jang M, Cai L, Udeani GO, Slowing KV, Thomas CF, Beecher CW, Fong HH, Farnsworth NR, Kinghorn AD, Mehta RG, et al: Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science. 275:218–220. 1997. View Article : Google Scholar : PubMed/NCBI
9	Soleas GJ, Diamandis EP and Goldberg DM: Resveratrol: a molecule whose time has come? and gone? Clin Biochem. 30:91–113. 1997. View Article : Google Scholar : PubMed/NCBI
10	Bradamante S, Barenghi L and Villa A: Cardiovascular protective effects of resveratrol. Cardiovasc Drug Rev. 22:169–188. 2004. View Article : Google Scholar : PubMed/NCBI
11	Das S and Das DK: Anti-inflammatory responses of resveratrol. Inflamm Allergy Drug Targets. 6:168–173. 2007. View Article : Google Scholar : PubMed/NCBI
12	de la Lastra CA and Villegas I: Resveratrol as an anti-inflammatory and anti-aging agent: mechanisms and clinical implications. Mol Nutr Food Res. 49:405–430. 2005. View Article : Google Scholar : PubMed/NCBI
13	Wu Z, Liu B, E C, Liu J, Zhang Q, Liu J, Chen N, Chen R and Zhu R: Resveratrol inhibits the proliferation of human melanoma cells by inducing G1/S cell cycle arrest and apoptosis. Mol Med Rep. 11:400–404. 2015.PubMed/NCBI
14	Yu XD, Yang JL, Zhang WL and Liu DX: Resveratrol inhibits oral squamous cell carcinoma through induction of apoptosis and G2/M phase cell cycle arrest. Tumour Biol. 37:2871–2877. 2016. View Article : Google Scholar : PubMed/NCBI
15	Trung L Quoc, Espinoza JL, Takami A and Nakao S: Resveratrol induces cell cycle arrest and apoptosis in malignant NK cells via JAK2/STAT3 pathway inhibition. PLoS One. 8:e551832013. View Article : Google Scholar : PubMed/NCBI
16	Pawlik TM and Keyomarsi K: Role of cell cycle in mediating sensitivity to radiotherapy. Int J Radiat Oncol Biol Phys. 59:928–942. 2004. View Article : Google Scholar : PubMed/NCBI
17	Fowler JF: The linear-quadratic formula and progress in fractionated radiotherapy. Br J Radiol. 62:679–694. 1989. View Article : Google Scholar : PubMed/NCBI
18	Wong JV, Dong P, Nevins JR, Mathey-Prevot B and You L: Network calisthenics: control of E2F dynamics in cell cycle entry. Cell Cycle. 10:3086–3094. 2011. View Article : Google Scholar : PubMed/NCBI
19	Lee AW, Sze WM, Au JS, Leung SF, Leung TW, Chua DT, Zee BC, Law SC, Teo PM, Tung SY, et al: Treatment results for nasopharyngeal carcinoma in the modern era: the Hong Kong experience. Int J Radiat Oncol Biol Phys. 61:1107–1116. 2005. View Article : Google Scholar : PubMed/NCBI
20	Das DK and Maulik N: Resveratrol in cardioprotection: a therapeutic promise of alternative medicine. Mol Interv. 6:36–47. 2006. View Article : Google Scholar : PubMed/NCBI
21	Pervaiz S and Holme AL: Resveratrol: its biologic targets and functional activity. Antioxid Redox Signal. 11:2851–2897. 2009. View Article : Google Scholar : PubMed/NCBI
22	Wang X, Ma S, Meng N, Yao N, Zhang K, Li Q, Zhang Y, Xing Q, Han K, Song J, et al: Resveratrol exerts dosage-dependent effects on the self-renewal and neural differentiation of hUC-MSCs. Mol Cells. 39:418–425. 2016. View Article : Google Scholar : PubMed/NCBI
23	García-Zepeda SP, García-Villa E, Díaz-Chávez J, Hernández-Pando R and Gariglio P: Resveratrol induces cell death in cervical cancer cells through apoptosis and autophagy. Eur J Cancer Prev. 22:577–584. 2013. View Article : Google Scholar : PubMed/NCBI
24	Xiong W, Yin A, Mao X, Zhang W, Huang H and Zhang X: Resveratrol suppresses human glioblastoma cell migration and invasion via activation of RhoA/ROCK signaling pathway. Oncol Lett. 11:484–490. 2016.PubMed/NCBI
25	Kma L: Synergistic effect of resveratrol and radiotherapy in control of cancers. Asian Pac J Cancer Prev. 14:6197–6208. 2013. View Article : Google Scholar : PubMed/NCBI
26	Fang Y, DeMarco VG and Nicholl MB: Resveratrol enhances radiation sensitivity in prostate cancer by inhibiting cell proliferation and promoting cell senescence and apoptosis. Cancer Sci. 103:1090–1098. 2012. View Article : Google Scholar : PubMed/NCBI
27	Liao HF, Kuo CD, Yang YC, Lin CP, Tai HC, Chen YY and Chen YJ: Resveratrol enhances radiosensitivity of human non-small cell lung cancer NCI-H838 cells accompanied by inhibition of nuclear factor-kappa B activation. J Radiat Res (Tokyo). 46:387–393. 2005. View Article : Google Scholar
28	Lu KH, Chen YW, Tsai PH, Tsai ML, Lee YY, Chiang CY, Kao CL, Chiou SH, Ku HH, Lin CH, et al: Evaluation of radiotherapy effect in resveratrol-treated medulloblastoma cancer stem-like cells. Childs Nerv Syst. 25:543–550. 2009. View Article : Google Scholar : PubMed/NCBI
29	Chaussepied M and Ginsberg D: Transcriptional regulation of AKT activation by E2F. Mol Cell. 16:831–837. 2004. View Article : Google Scholar : PubMed/NCBI
30	Korotayev K, Chaussepied M and Ginsberg D: ERK activation is regulated by E2F1 and is essential for E2F1-induced S phase entry. Cell Signal. 20:1221–1226. 2008. View Article : Google Scholar : PubMed/NCBI